Following the statement made by Maria Sharapova in a press conference today, the Tennis Anti-Doping Programme (TADP) can confirm the following:
The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the Tennis Anti-Doping Programme and World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping.
18 September 2019
Roger Federer plans to decide "in the next month or so" whether he will play at next year'... More
6 June 2017
French Open quarterfinalist Kristina Mladenovic has opened up about her split with former ... More
9 January 2018
As the first Grand Slam of the season fast approaches, top-10 players are leading the char... More